Remdesivir/Verapamil: Lack of efficacy : case report.

A 40-year-old man with a history of hypertension, diabetes, and bronchial asthma, who was also a smoker, was treated for COVID-19 with remdesivir and verapamil. After initially improving, he experienced cough, chest pain, and difficulty breathing. Despite treatment with verapamil, he had a hypertensive crisis and his condition worsened. He developed a spontaneous pneumothorax and despite further treatment, including remdesivir, his oxygen saturation did not improve. He ultimately passed away due to cardiac arrest and COVID-19. [Extracted from the article]

Copyright of Reactions Weekly is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)